期刊文献+

重组人内皮抑素PEG-PE胶束的制备及抑瘤效应研究 被引量:3

Preparation of encapsulation of recombinant human endostatin in PEG-PE micelles and inhibition effects on tumor cells growth and neovascularization of CAM
下载PDF
导出
摘要 目的:内皮抑素是强效的血管内皮细胞生长抑制剂,但其低溶解度限制了临床应用,通过采用聚乙二醇衍生化磷脂酰乙醇胺(PEG-PE)制备包载重组人内皮抑素的胶束,以期寻找内皮抑素的新药物载体。方法:研究PEG-PE内皮抑素胶束的理化性质,观察PEG-PE内皮抑素胶束对体外肿瘤细胞生长的作用及对鸡胚绒毛尿囊体内血管生长的影响。结果:制备的PEG-PE-内皮抑素胶束的粒径为(48.32±8.29)nm,Zeta电位为+3.2 mV。包封率为75%,该胶束可以抑制MCF-7肿瘤细胞的生长和增殖,内皮抑素浓度50μg.mL-1时抑制率为31.4%,对鸡胚绒毛尿囊血管新生也有明显的抑制作用。结论:同单独用内皮抑素比较,用PEG-PE胶束作为药物载体运送内皮抑素直接抑制肿瘤细胞生长和抑制新生血管形成的效果更明显。 Objective: Recombinant human endostatin (rhEndostatin) have been shown to inhibit vascular endothelial proliferation. However, low solubility of rhEndostatin limits its therapeutic potential. In order to obtain an effective delivery system pemitting transported rhEndostatin into tumor cell, phospholipid micelles made of polyethyleneglycol phosphatidyl ethanolamine (PEG-PE) was studied. Methods: The size and morphology of micelles encapsulating rhEndostatin were examined using dynamic light scattering (DLS) and transmission electron microscopy (TEM). The entrapment efficiency in micelles was investigated by the high speed centrifugation method. The corresponding in vitro antitumor effect of encapsulation of rhEndostatin in PEG-PE micelles was obtained on MCF-7 cells from 3-(4, 5- dimethylthiazol-2-yl ) -2,5-diphenyhetrazolium bromide (MTF) assay. The inhibition of neovascularization was studied by chicken embryo chorioallantoic membrane (CAM). Results: The mean diameter of the rhEndostatin -encapsulated micelles was 48. 32 nm with narrow size distribution. Encapsulation efficiency in micelles was 75%. The micellar rhEndostatin exhibited an irregular spherical shape from TEM photographs. Encapsulation of this micelles was demonstrated significant antitumor activity on MCF-7 cell proliferation, with an inhibition rate of 31.4% when the concentration of rhEndostatin was at 50 μg·mL^-1. And neovascularization in CAM was inhibited efficiently compared to the rhEndostatin alone. Gonclusion: Encapsulation of rhEndostatin in PEG-PE micelles are effective compound in inhibiting tumor cell growth and vascular endothelial prolification compared to rhEndostatin.
出处 《药学与临床研究》 2009年第3期163-167,共5页 Pharmaceutical and Clinical Research
基金 国家863目标导向基金项目(2006AA02Z19E) 江苏省自然科学基金项目(BK2008150)
关键词 PEG-PE 内皮抑素 重组人内皮抑素 胶束 药物载体 PEG-PE Endostatin RhEndostatin Liposome Drug delivery
  • 相关文献

参考文献8

二级参考文献47

  • 1聂明明,方国恩,王星华,苏长青,崔贞福,李林芳,钱其军.基因-病毒治疗系统CNHK300-murine endostatin的构建及体外研究[J].中华实验外科杂志,2006,23(1):45-48. 被引量:12
  • 2Wirth T, Zender L, Sehulte B, et al. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Res, 2003, 63:3181-3188.
  • 3Qian Q, Sham J, Che X, et al. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously. Chin Med J(Engl), 2002, 115:1213-1217.
  • 4Cao YH. Antiangiogenic gene therapy. Gene Therapy Regulation,2000, 1:123-139.
  • 5Smith ER, Chiocca EA. Oncolytic viruses as novel anticancer agents:turning one scourage against another. Exp Opin Invest Drugs, 2000, 9:311-327.
  • 6Rodriguez R, Schuur ER, Lira HY, et al. Prostate attenuated replication competent adenovirus (ARCA)CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res,1997, 57:2559-2563.
  • 7Ohashi M, Kanai F, Tateishi K, et al. Target gene therapy for α-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus. Biochem Biophys Res Commun, 2001,282: 529-535.
  • 8Chen L, Chen D, Manome Y, et al. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1promoter.J Clin Invest, 1995, 96:2775-2785.
  • 9Shay JW, Baccherti S. A survey of telomerase activity in human cancer.Eur J Cancer, 1997, 33:787-791.
  • 10Shay JW, Wright WE. Telomeres and telomerase: implication for cancer and aging. Radiation Research, 2001, 155: 188-193.

共引文献46

同被引文献29

  • 1Jorgensen R. Plants, RNAi, and the Nobel Prize [J]. Science, 2006, 314(5803): 1242-3.
  • 2Sun X, Rogoff HA, Li CJ. Asymmetric RNA duplexes mediate RNA interference in mammalian cells [J]. Na- ture Biotechnology, 2008, 26(12): 1379-82.
  • 3Castagna A, Biswas P, Beretta A, et al. The appealing story of HIV entry inhibitors: from discovery of biologi- cal mechanisms to drug development [J]. Drugs, 2005, 65(7): 879-904.
  • 4Strayer DS, Akkina R, Bunnell BA, et al. Current sta- tus of gene therapy strategies to treat HIV/AIDS[J]. Mol Ther, 2005, 11(6): 823-42.
  • 5Ge HJ, Wu ZW. Down regulation of CCR5 by asym- metric siRNA duplex-mediated RNA interference [J]. J Nanjing Univ, 2010, 46: 96-9.
  • 6Savic R, Luo L, Eisenberg A, et al. Micellar nanocon- tainers distribute to defined cytoplasmic organelles[J]. Science, 2003, 300(5619): 615-8.
  • 7Wu J, Ding D, Ren G, et al. Sustained delivery of en- dostatin improves the efficacy of therapy in Lewis lung cancer model [J]. J Controlled Release, 2008, 134(2): 91-7.
  • 8O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997, 88(2): 277-85.
  • 9Folkman J. Antiangiogenesis in cancer therapy-endo- statin and its mechanisms of action [J]. Exp Cell Res, 2006, 312(5): 594-607.
  • 10Hornand L, Sandle A. Angiogenesis inhibitors in lung cancer[J]. Cur Oncol Reports, 2002, 4(4): 325-33.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部